2021-01-07,"Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Insiders Increased Their Holdings"
2021-01-04,Protagonist Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-29,MannKind (MNKD) Looks Good: Stock Adds 5.6% in Session
2020-12-17,Protagonist (PTGX) Begins Dosing in Phase I Study With PN-235
2020-12-16,Protagonist Therapeutics Announces First Subject Dosed in Phase 1 Study of Oral IL-23 Receptor Antagonist PN-235 (JNJ-77242113)
2020-12-15,"Protagonist Therapeutics, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares"
2020-12-13,Is PTGX A Good Stock To Buy Now?
2020-12-10,"Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock"
2020-12-10,"Protagonist Therapeutics, Inc. Announces Proposed Public Offering of Common Stock"
2020-12-07,Protagonist Announces Results of Large-Scale Analysis of Current Treatment Patterns Revealing Significant Opportunity to Improve the Standard of Care for Patients with Polycythemia Vera Across Broad Population Categories
2020-12-06,Protagonist Announces Updated Phase 2 Data Presented at ASH Annual Meeting Supporting Long Term Efficacy of Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera
2020-12-02,Protagonist's Hepcidin Mimetic Candidate PTG-300 Receives Fast Track Designation from the U.S. Food and Drug Administration for Development in the Treatment of Polycythemia Vera
2020-12-01,Protagonist Therapeutics Reports Granting of Inducement Award
2020-11-30,"Protagonist to Host Conference Call and Webcast to Provide a Research Update on December 9, 2020"
2020-11-25,Protagonist Therapeutics to Present at the Virtual Piper Sandler 32nd Annual Healthcare Conference
2020-11-11,Protagonist Therapeutics to Participate in the Jefferies Virtual 2020 London Healthcare Conference
2020-11-04,"Protagonist Therapeutics (PTGX) Reports Q3 Loss, Tops Revenue Estimates"
2020-11-04,Protagonist Therapeutics Reports Third Quarter Financial Results and Provides Corporate Update
2020-11-04,Protagonist Therapeutics to Present Updated Clinical Data for Hepcidin Mimetic PTG-300 in Polycythemia Vera at the American Society for Hematology (ASH) 2020 Annual Meeting
2020-10-30,Protagonist Therapeutics Reports Granting of Inducement Award
2020-10-29,Protagonist Therapeutics Announces Advancement of Oral IL-23 Receptor Antagonists Program in Collaboration with Janssen
2020-10-28,Protagonist Therapeutics (PTGX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
2020-10-21,Protagonist Therapeutics Receives Orphan Drug Designation from the European Medicines Agency for PTG-300 in Polycythemia Vera
2020-10-09,Here's What We Think About Protagonist Therapeutics' (NASDAQ:PTGX) CEO Pay
2020-09-17,Protagonist Therapeutics to Participate in the Jefferies Next Generation IBD Therapeutics Virtual Summit 2020
2020-09-15,Protagonist Therapeutics Reports Granting of Inducement Award
2020-09-10,Protagonist Therapeutics to Participate in the H.C. Wainwright 22nd Annual Global Investment Conference
2020-09-02,Protagonist Therapeutics to Host PTG-300 Opportunity Update Webinar
2020-08-25,Can You Imagine How Protagonist Therapeutics' (NASDAQ:PTGX) Shareholders Feel About The 64% Share Price Increase?
2020-08-13,Protagonist Appoints Sarah O'Dowd to Board of Directors
2020-08-06,"Protagonist Therapeutics (PTGX) Reports Q2 Loss, Tops Revenue Estimates"
2020-08-06,Protagonist Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
2020-07-29,Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
2020-06-27,"Protagonist Therapeutics, Inc. (PTGX): Are Hedge Funds Right About This Stock?"
2020-06-18,Protagonist Therapeutics' PTG-300 Gets FDA's Orphan Drug Tag
2020-06-17,Hepcidin Mimetic PTG-300 Receives U.S. FDA Orphan Drug Designation for the Treatment of Polycythemia Vera
2020-06-16,Protagonist Therapeutics to Participate in the BMO Prescriptions for Success Healthcare Conference
2020-06-15,Edited Transcript of PTGX.OQ earnings conference call or presentation 7-May-20 9:00pm GMT
2020-06-04,Protagonist Therapeutics to Present at the 25th European Hematology Association (EHA) Annual Congress
2020-05-28,Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences
2020-05-28,Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease
2020-05-18,"Analysts Just Made A Major Revision To Their Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Revenue Forecasts"
2020-05-12,"Protagonist Therapeutics, Inc. Announces Upsizing and Pricing of Underwritten Public Offering of 7,000,000 Shares of Common Stock"
2020-05-11,"Company News for May 11, 2020"
2020-05-11,"Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates"
2020-05-11,"Protagonist Therapeutics, Inc. Announces Proposed Underwritten Public Offering of Common Stock"
2020-05-11,3 Small-Cap Biotech Stocks That Surged Last Week
2020-05-10,"Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2020 Earnings Call Transcript"
2020-05-08,Why Did Protagonist Therapeutics (PTGX) Soar 83.7% Today?
2020-05-08,Why Protagonist Therapeutics Is Skyrocketing Today
2020-05-08,Protagonist Therapeutics: Price Over Earnings Insights
2020-05-07,Protagonist Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
2020-05-07,Protagonist Therapeutics Announces Initial Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Polycythemia Vera
2020-05-01,"What Does The Future Hold For Protagonist Therapeutics, Inc. (NASDAQ:PTGX)? These Analysts Have Been Cutting Their Estimates"
2020-04-21,"How Much is Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Getting Paid?"
2020-04-15,Protagonist Therapeutics Reports Granting of Inducement Award
2020-03-28,Edited Transcript of PTGX earnings conference call or presentation 10-Mar-20 8:30pm GMT
2020-03-13,"Trade Alert: The Chairman Of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), Harold Selick, Has Just Spent US$80k Buying Shares"
2020-03-10,"Protagonist Therapeutics (PTGX) Reports Q4 Loss, Lags Revenue Estimates"
2020-03-10,Protagonist Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
2020-03-10,"Protagonist Therapeutics, Inc. to Host Earnings Call"
2020-03-03,Analysts Estimate Protagonist Therapeutics (PTGX) to Report a Decline in Earnings: What to Look Out for
2020-03-02,Protagonist Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Results
2020-02-19,Protagonist Therapeutics to Present at the SVB Leerink 9th Annual Global Healthcare Conference in New York
2020-02-11,"How Does Investing In Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Impact The Volatility Of Your Portfolio?"
2020-02-07,Protagonist Therapeutics to Present Preclinical Results on PN-943 at the 15th Congress of European Crohn's and Colitis Organization (ECCO)
2020-01-07,Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder
2020-01-07,"Protagonist Therapeutics Achieves Milestone in Janssen Biotech, Inc., Collaboration"
2020-01-06,Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Hereditary Hemochromatosis
2019-12-12,"Here is What Hedge Funds Think About Protagonist Therapeutics, Inc. (PTGX)"
2019-12-11,"Insider Buying: The Protagonist Therapeutics, Inc. (NASDAQ:PTGX) CEO, President Just Bought US$169k Worth Of Shares"
2019-12-04,"The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug"
2019-12-03,Protagonist Therapeutics Announces Preliminary Phase 2 Results with Hepcidin Mimetic PTG-300 in the Treatment of Transfusion Dependent Beta-Thalassemia
2019-11-13,Protagonist Therapeutics to Present at Two Upcoming Healthcare Investor Conferences
2019-11-06,"Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates"
2019-11-06,Protagonist Therapeutics Reports Third Quarter 2019 Financial Results
2019-11-06,Protagonist Therapeutics Announces First Patient Dosed in a Phase 2 Study of Oral IL-23 Receptor Antagonist PTG-200 (JNJ-67864238) in the Treatment of Crohn's Disease
2019-10-31,Protagonist Therapeutics Secures Debt Facility for up to $50 Million
2019-10-29,Earnings Preview: Protagonist Therapeutics (PTGX) Q3 Earnings Expected to Decline
2019-10-22,"The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug"
2019-10-20,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict"
2019-10-02,The Protagonist Therapeutics (NASDAQ:PTGX) Share Price Is Down 45% So Some Shareholders Are Getting Worried
2019-10-01,Protagonist Therapeutics Announces Acceptance of Abstracts at the UEG Week 2019 Meeting and the ACG 2019 Annual Scientific Meeting
2019-09-25,"Protagonist Therapeutics to Present at the Cantor Global Healthcare Conference on Wednesday, October 2"
2019-09-04,Protagonist Therapeutics Reports Granting of Inducement Awards
2019-09-03,Protagonist Therapeutics to Present at the H.C. Wainwright & Co. 2019 Annual Healthcare Conference
2019-08-27,"Does Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Salary Reflect Performance?"
2019-08-07,"Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-07,Protagonist Therapeutics Reports Second Quarter 2019 Financial Results
2019-08-01,Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Sustained Dose-Related Target Engagement Activity in a Multiple Ascending Dose Phase 1 Study
2019-07-30,Protagonist Therapeutics (PTGX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2019-07-16,Protagonist Therapeutics Reports Granting of Inducement Award
2019-07-11,"Should You Be Worried About Insider Transactions At Protagonist Therapeutics, Inc. (NASDAQ:PTGX)?"
2019-06-23,"Heres What Hedge Funds Think About Protagonist Therapeutics, Inc. (PTGX)"
2019-06-18,Protagonist Therapeutics Reports Granting of Inducement Award
2019-06-17,Protagonist Therapeutics to Present at the BMO 2019 Prescription for Success Healthcare Conference
2019-06-04,Protagonist Therapeutics Reports Granting of Inducement Award
2019-05-29,Protagonist Therapeutics Appoints Don Kalkofen as Chief Financial Officer
2019-05-15,"Protagonist Therapeutics, Inc. Common Stock (PTGX) Q1 2019 Earnings Call Transcript"
2019-05-14,Oral Alpha-4-Beta-7 Integrin Antagonist PN-943 Demonstrates Superior Dose-Related Target Engagement Activity to PTG-100 in Single Ascending Dose Phase 1 Study
